The American Medical Association (AMA) released a statement on March 4 warning against the against a “test-totreat” plan that the Biden administration has proposed saying the approach “flaunts patient safety and risks significant negative health outcomes.”
“The AMA is pleased the administration is ramping up supply of antivirals so in the near future they will be broadly ava...
To access content, please login or purchase a subscription.